Physician

Adam G. Manko, MD

According to 2025 Medicare claims, Adam Manko, MD (NPI: 1316266190) practices pulmonary disease in the Columbus, OH market, with the plurality of this provider's patient population coming from Madison, OH. This provider's primary affiliated billing organization is OSUP COMMUNITY OUTREACH LLC (NPI: 1699179929; TIN: 46-3580388) and primary practice location at 43140-1115.

Manko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 208 traditional Medicare patients, billed 840 HCPCS/CPT codes, and received $40,218 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,638 prescription claims across 426 beneficiaries totaling $2,075,828 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,000 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $84,473 to $40,218. In contrast, Part D prescription costs have moved sharply higher in recent years, from $27,519 to $2,075,828. For DME billing, reported payments moved sharply higher in recent years, from $1,178 to $55,567.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	349	890	$84,473
2017	726	2,060	$162,191
2018	342	1,015	$84,591
2019	333	1,037	$69,351
2020	188	996	$59,926
2021	190	944	$59,773
2022	187	838	$49,147
2023	222	975	$57,977
2024	208	840	$40,218

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	119	$27,519
2016	56	173	$17,113
2017	103	383	$53,354
2018	84	351	$77,420
2019	181	878	$266,118
2020	276	2,036	$694,308
2021	306	2,562	$1,034,721
2022	349	2,641	$1,459,010
2023	388	3,191	$1,799,725
2024	426	3,638	$2,075,828

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	29	$93
2018	85	348	$6,643
2019	205	738	$38,416
2020	149	784	$50,498
2021	94	577	$33,807
2022	77	647	$36,871
2023	171	897	$50,432
2024	264	1,000	$59,319

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	230	$78
94010	Test to measure expiratory airflow and volume	50	51	$18
94726	Test to determine lung volumes using sensors	54	58	$8
94060	Test to measure expiratory airflow and volume changes before and after medication administration	54	58	$7
94729	Test to examine how well the lungs exchange gases	54	58	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	636	24,840	$530,107
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	446	16,078	$339,340
Ofev	Nintedanib Esylate	21	630	$276,825
Nucala	Mepolizumab	62	1,736	$248,954
Adempas	Riociguat	12	360	$166,712

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	24	$18,256
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	28	201	$13,825
E0601	Continuous positive airway pressure (cpap) device	Y	18	97	$3,181
A7031	Face mask interface, replacement for full face mask, each	N	17	34	$2,561
A7030	Full face mask used with positive airway pressure device, each	N	16	32	$2,522

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Adam G. Manko, MD?

Tedicare shows public-source Medicare data for Adam G. Manko, MD (NPI 1316266190), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam G. Manko, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam G. Manko, MD?

Adam G. Manko, MD is linked to OSUP COMMUNITY OUTREACH LLC (billing NPI 1699179929) in the available physician profile data.

Does Adam G. Manko, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.